Organization | IRC Clinics, Towson

IRC Clinics, Towson Report issue

Academic/Hospital Phase 2

Founded: Towson MD United States (1996)

Organization Overview

First Clinical Trial

2012

NCT01728753

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Alternative names

IRC Clinics | IRC Clinics, | IRC Clinics, Towson, MD 21204

Active Ingredients

Drugs in Phase 2 Trials (3)

favipiravir (1 trial)

nmvac4-a/c/y/w-135-dt (1 trial)

quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diphtheria (Phase 2)

Influenza, Human (Phase 2)

Meningitis (Phase 2)

Meningitis, Meningococcal (Phase 2)

Meningococcal Infections (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 2
# of Trial APIs: 3